Dr. Reddy’s partners DST, UoH to develop anti-psoriatic drugs

24 May 2017 Evaluate

Dr. Reddy’s Laboratories (DRL) has joined hands with the Department of Science and Technology (DST) and University of Hyderabad (UoH) to initiate a project on discovery and development of anti-psoriatic drugs. The three entities have inked an agreement for the same. The venture, valued at Rs 1.90 crore, has been sponsored by DST and DRL.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.



Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×